f
t
i
x
Menu
Toggle navigation
Home
US TOO International
Us TOO Mission & Vision
The Value of Us TOO
Welcome
Leadership & Staff
Affiliated Support Groups
Support Group Leader Resources
Recent Emails from Us TOO
501(c)3 Status
Us TOO Reports
Education Videos on Informed Decision Making
History of Us TOO
Outreach & News
Us TOO Media Kit
Prostate Cancer
Educational Videos / Informed Decision Making
Facts & Stats
Detection - PSA & DRE
Genetics & Genomic Testing
Newly Diagnosed
Treatment Options
Prostate Cancer Drugs
Anxiety & Depression
Other Side Effects
Relapse
Advanced Prostate Cancer
Clinical Trials
Studies & Surveys
Emerging Treatments
Glossary
Those Affected
Why You Should Care
Risk Factors
Military Veterans
Spouses/Partners/Family
“SEA Stories” – About Prostate Cancer Support, Education & Advocacy
Healthcare Professionals
Us TOO Volunteers
Education & Support
Find a Support Group
Start a Support Group
Join an Online Prostate Cancer Support Community
Join a Phone Support Group
Call the HelpLine
Find One-to-One Support
Read the Hot SHEET Newsletter
Find “News You Can Use”
Attend Educational Events
Read Educational Materials
Request Printed Materials
Navigate My Prostate Cancer Roadmap
Get the Physicians’ Perspective
Volunteer to Help
Find Financial Assistance
Access Additional Resources
Help Us TOO Help Others
SEA Blue Chicago Prostate Cancer Walk & Run
Donate to Us TOO
Donate – Planned Giving
Donate – Appreciated Stock
Donate - Memorial Gift
Donate - Tribute Gift
eBay Giving Works
Corporate Support/Sponsorship
Volunteer Opportunities
Contact Us
Hot Sheets 2008- UsToo Internationl
Home
US TOO International
Us TOO Mission & Vision
The Value of Us TOO
Welcome
Leadership & Staff
Affiliated Support Groups
Support Group Leader Resources
Recent Emails from Us TOO
501(c)3 Status
Us TOO Reports
Education Videos on Informed Decision Making
History of Us TOO
Outreach & News
Us TOO Media Kit
Prostate Cancer
Educational Videos / Informed Decision Making
Facts & Stats
Detection - PSA & DRE
Genetics & Genomic Testing
Newly Diagnosed
Treatment Options
Prostate Cancer Drugs
Anxiety & Depression
Other Side Effects
Relapse
Advanced Prostate Cancer
Clinical Trials
Studies & Surveys
Emerging Treatments
Glossary
Those Affected
Why You Should Care
Risk Factors
Military Veterans
Spouses/Partners/Family
“SEA Stories” – About Prostate Cancer Support, Education & Advocacy
Healthcare Professionals
Us TOO Volunteers
Education & Support
Find a Support Group
Start a Support Group
Join an Online Prostate Cancer Support Community
Join a Phone Support Group
Call the HelpLine
Find One-to-One Support
Read the Hot SHEET Newsletter
Find “News You Can Use”
Attend Educational Events
Read Educational Materials
Request Printed Materials
Navigate My Prostate Cancer Roadmap
Get the Physicians’ Perspective
Volunteer to Help
Find Financial Assistance
Access Additional Resources
Help Us TOO Help Others
SEA Blue Chicago Prostate Cancer Walk & Run
Donate to Us TOO
Donate – Planned Giving
Donate – Appreciated Stock
Donate - Memorial Gift
Donate - Tribute Gift
eBay Giving Works
Corporate Support/Sponsorship
Volunteer Opportunities
Contact Us
HotSheets by Year
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
HotSheets 2008
January
February
March
April
May
June
July
August
September
October
November
December
January
|
Newsletter
Overall Survival Analysis of SPARC Trial
Patients Often Get Contraindicated Therapy
Us TOO’s 2008 Board Members/Officers
Post-Prostatectomy Incontinence Treatment
Letter to the Editor
Doc Moyad’s What Works and What is Worthless Column—Statins
Read more..
February
|
Newsletter
Senate Passes Last-Minute ‘Rescue” for Doctors Facing Big Medicare Cuts
Aspirin Impairs Prostate Cancer Treatment
More FDA Action Possible for ESAs
Cancer Tool Shows Promise in Scottsdale
Hormones Delay Prostate Cancer Growth
Research Yields Clues to Cancer Recurrence
Read more..
March
|
Newsletter
Supreme Court Declines Review in the Abigail Alliance Experimental Drug Case
Editorial: Provenge Pressure Builds on FDA
Cell Genesys’ Clinical Trials to Continue
Supreme Court Sides with Washington University in Tissue Ownership Case
No Link Between Androgen and Risk for PCa
Us TOO Raises Minority Cancer Awareness
Read more..
April
|
Newsletter
Special Burning Issues Supplement:
Highlights from ASCO’s 2008 Genitourinary Cancers Symposium—San Francisco, CA, February 14-16, 2008
New Analysis Out on Cancer Drug
GTx’s Toremifene Meets Primary Endpoints
Treatment Decision-Making Not Easy
The Power of Words for Cancer Patients
April Brings a New Look to SEA Blue for National Minority Cancer Awareness Week
Genetic Variants Found to be Associated with Prostate Cancer
Read more..
May
|
Newsletter
Doctors Use “GPS for the Body” to Target Cancer Cells
Takeda, Cell Genesys Partner to Develop Prostate Cancer Vaccine
Blood Test Indicates Nodal Spread in Localized Prostate Cancer
Medicare Changes Influenced Prostate Cancer Treatment Decisions
New Information Drives Changes in Bladder Control Treatment
Outer–Course vs. Inter-Course
Geneve Bio Developing Revolutionary Curative ED Treatment
Read more..
June
|
Newsletter
Experimental Vaccine Shows Promise in Prostate Cancer
Celebrex-Lipitor Combination May Halt Prostate Cancer
Prostate Cancer Mortality Declining Faster in the United States than in Britain
Iowa, Arizona Expand on SEA Blue African American Awareness Campaign
Similar Survival with Salvage Surgery (RP) and Radiotherapy (RT)
Gene Activity and Cancer’s Racial Divide
Nanotechnology Enhances Early Detection of Prostate Cancer in Black Males
Read more..
July
|
Newsletter
New Analysis Boost’s Finasteride’s Value
Active Surveillance Still a Viable Option
Adjuvant Radiation Shows Promise for High-Risk Surgery Patients
Kennedy Has Major Cancer Bill in Senate
Prostate Cancer Vaccine Linked to Improved Survival in Small Trial
Amgen Reports Positive Data at ASCO for Denosumab in Cancer Patients
‘Equivocal’ Antioxidant Effects in Cancer Therapy
Read more..
August
|
Newsletter
Pints for Prostates Delivers Men’s Health Message
Mrs. Illinois 2008 Supports Prostate Cancer Awareness and Us TOO International
Proscar® Lowers Prostate Cancer Risk in All Men
Radiation May Help After Prostate Cancer Setback
GPC Biotech Announces NCI-Sponsored Phase 2 Trial of Satraplatin in Metastatic HRPC
Doc Moyad’s “What Works and What Is Worthless Column”—Saturated Fat
Read more..
September
|
Newsletter
Prostate Test Advice for Elderly Won’t Stop Debate
First Annual Edward C. Kaps Hope Award Winners Announced
Amgen Announces Positive Results for Denosumab
Do You Know Where Your Prostate Cancer Tissue Is?
Early Findings Create Buzz for Potent Novel Hormone Blocker
Us TOO Seeks Board Member Nominations
Read more..
October
|
Newsletter
Cell Genesys Halts GVAX Trial
The Wrong Call on Prostate Cancer Screening
Blood Calcium Tied to Lethal Prostate Cancer
Researchers Find Prostate Cancer Gene
Regular NSAID Use May Reduce PSA Levels
2nd Annual Cancer Awareness Days in NJ
Doc Moyad’s "What Works and What Is Worthless Column"— I.V. Vitamin C
Read more..
November
|
Newsletter
Radiation Added to Androgen Deprivation Therapy Halves Risk of Prostate Cancer Death
Dendreon Announces Interim Data from Phase 3 Provenge IMPACT Trial
Novacea Has No Plans to Develop Asentar®
Understanding Scientific Studies & Reports – Determining What’s Good & What’s Not
The Patient as Healer – How to Alleviate Your Pain and Stress
Proton Radiation Fails to Impress in Prostate Cancer Study
Read more..
December
|
Newsletter
Cell Genesis Announces Termination of Phase 3 VITAL-1 GVAX Clinical Trial
Vitamin E and Selenium Do Not Prevent Prostate Cancer: Large-Scale Study Stopped
AUA Best Practice Statement Recommends Cryosurgery in Certain Prostate Cancer
Rethinking Prostate Cancer in Older Men
Prostate Cancer Awareness Events: Greater Chicago Prostate Cancer Run Walk ‘n Roll
Lawyer, Mountain Climber Names Us TOO As Beneficiary
Read more..
×
Log In
Email
(*)
Password
(*)
CLICK HERE
and opt-in to receive free educational emails from Us TOO.